Remove Insurance Remove Pharma Remove Prescription Remove Specialization
article thumbnail

Edelman Trust Barometer raises questions

World of DTC Marketing

After two years of pandemic fatigue, healthcare trust is at an all-time low, according to Edelman’s Trust Barometer Special Report on Trust in Healthcare. consumers’ trust in pharma is low, despite the industry’s contributions to ending the pandemic: Only 15% of U.S. If so, they are going to ve disappointed.

article thumbnail

Fewer Prescribers Are Driving NBRx Than You Think—Here’s Why

PM360

According to a 2021 study by Statista, 40% of prescriptions written in 2005 were for brand-name medications. 1 How is this possible, given that more than 20,000 prescription drugs are currently in circulation in the U.S. 1 How is this possible, given that more than 20,000 prescription drugs are currently in circulation in the U.S.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Pharma Injecting Life into Digital Health Amidst Funding Downturn

MedCity News

Numerous clinical, regulatory and financial factors are behind this digital shift in pharma.

Pharma 98
article thumbnail

Handling Economic Uncertainty: The Focus Pharma Marketers Need

Eversana Intouch

Let’s talk about the current economic uncertainty and what it means for pharma marketers. Talent shortages continue, particularly in executive and specialized R&D roles, while simultaneously layoffs , especially in biotech, are on the rise. What does this mean for pharma marketers? What’s the current situation?

article thumbnail

Handling Economic Uncertainy: The Focus Pharma Marketers Need

Eversana Intouch

Let’s talk about the current economic uncertainty and what it means for pharma marketers. Talent shortages continue, particularly in executive and specialized R&D roles, while simultaneously layoffs , especially in biotech, are on the rise. What does this mean for pharma marketers? What’s the current situation?

article thumbnail

Improving COVID Care Delays: How Pharma Companies Can Help Patients

PM360

alone—but it hit pause on an industry used to providing in-person medical care, specialized surgical procedures, and routine health screenings to hundreds of millions of people annually. 9 According to Solis and Schulman, 62% of patients with chronic conditions before COVID were responsible for 80% of the drop in new prescriptions.

article thumbnail

Specialty Treatments Require a New Approach to Affordability

PM360

As a mission-driven company and digital healthcare leader, GoodRx has helped patients obtain an estimated 80 million prescriptions they otherwise may not have been able to afford. Figure 1: Share of net spending for specialty and traditional prescription medications. Source: IQVIA Institute, March 2022.